EPO Does Not Improve Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy - YakTriNews KAPP-KVEW
7/14/2022 12:00:00 AM2 years 9 months ago
by Physician’s Briefing Staff
by Physician’s Briefing Staff
Death, neurodevelopmental impairment rates similar for newborns receiving erythropoietin, or placebo, combined with therapeutic hypothermia
THURSDAY, July 14, 2022 (HealthDay News) -- For newborns undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy, erythropoietin administration does not yield a lower risk for death or… [+1530 chars]
full article...